Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux the FUTURA/OASIS-8

Abstract

Summary - This multicenter study FUTURA OASIS-8 randomized trial brings comarison of two dose-schemes of unfractionated heparin prior to fondaparinux therapy in patiens with acute coronary syndromes.

Keywords

• Activated clotting time
• european society
• task-force
• revascularization
• anticoagulation
• angioplasty
• cardiology
• enoxaparin
• outcomes
• therapy